Jounce Therapeutics, Inc.

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

14,660

Value ($000)

Weight

0.0%

2020 Q2 - 2023 Q1 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	27	0.0%	14,660	3/31/2023
2022 Q3	11/16/2022	83	0.0%	35,599	9/30/2022
2022 Q2	8/23/2022	68	0.0%	22,500	6/30/2022
2022 Q1	5/16/2022	166	0.0%	24,500	3/31/2022
2021 Q4	2/14/2022	205	0.0%	24,500	12/31/2021
2021 Q3	11/16/2021	182	0.0%	24,500	9/30/2021
2021 Q2	8/16/2021	167	0.0%	24,500	6/30/2021
2021 Q1	5/17/2021	221	0.0%	21,500	3/31/2021
2020 Q4	2/16/2021	80	0.0%	11,500	12/31/2020
2020 Q3	11/17/2020	99	0.0%	11,000	9/30/2020
2020 Q2	8/14/2020	73	0.0%	11,000	6/30/2020